wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36931790-032060FA-1476-410F-989A-32948FBC0B13
Q36931790-032060FA-1476-410F-989A-32948FBC0B13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36931790-032060FA-1476-410F-989A-32948FBC0B13
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene
P2860
Q36931790-032060FA-1476-410F-989A-32948FBC0B13
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36931790-032060FA-1476-410F-989A-32948FBC0B13
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4a3f53ede42694b3059eafe638fc8ba971f9f233
P2860
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.